Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_assertion type Assertion NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_head.
- NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_assertion description "[A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_provenance.
- NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_assertion evidence source_evidence_literature NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_provenance.
- NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_assertion SIO_000772 12890841 NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_provenance.
- NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_assertion wasDerivedFrom befree-20150227 NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_provenance.
- NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_assertion wasGeneratedBy ECO_0000203 NP772396.RAeKQ_wjjFVHYLNYXmYBCI1f_P4mEeOQSPpBohSE2TQjA130_provenance.